BAIT
AR
AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM, RP11-383C12.1
androgen receptor
GO Process (23)
GO Function (16)
GO Component (5)
Gene Ontology Biological Process
- androgen receptor signaling pathway [IDA]
- cell growth [NAS]
- cell proliferation [NAS]
- cell-cell signaling [TAS]
- gene expression [TAS]
- intracellular receptor signaling pathway [IDA]
- negative regulation of extrinsic apoptotic signaling pathway [IDA]
- negative regulation of integrin biosynthetic process [IDA]
- positive regulation of NF-kappaB transcription factor activity [IMP]
- positive regulation of cell proliferation [IDA]
- positive regulation of integrin biosynthetic process [IDA]
- positive regulation of phosphorylation [IMP]
- positive regulation of transcription from RNA polymerase II promoter [IDA, IMP]
- positive regulation of transcription from RNA polymerase III promoter [IDA]
- positive regulation of transcription, DNA-templated [IDA]
- prostate gland development [NAS]
- protein oligomerization [IDA]
- regulation of establishment of protein localization to plasma membrane [IDA]
- sex differentiation [NAS]
- signal transduction [TAS]
- transcription initiation from RNA polymerase II promoter [TAS]
- transcription, DNA-templated [IDA]
- transport [TAS]
Gene Ontology Molecular Function- DNA binding [NAS]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding [IDA]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [IDA]
- RNA polymerase II transcription factor binding [IPI]
- androgen binding [NAS]
- androgen receptor activity [IDA, IMP, NAS, TAS]
- beta-catenin binding [IDA, IPI, TAS]
- chromatin binding [IDA]
- enzyme binding [IPI]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- protein binding [IPI]
- protein dimerization activity [NAS]
- receptor binding [IPI]
- sequence-specific DNA binding transcription factor activity [IDA]
- transcription factor binding [IPI]
- transcription regulatory region DNA binding [IDA]
- DNA binding [NAS]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding [IDA]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [IDA]
- RNA polymerase II transcription factor binding [IPI]
- androgen binding [NAS]
- androgen receptor activity [IDA, IMP, NAS, TAS]
- beta-catenin binding [IDA, IPI, TAS]
- chromatin binding [IDA]
- enzyme binding [IPI]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- protein binding [IPI]
- protein dimerization activity [NAS]
- receptor binding [IPI]
- sequence-specific DNA binding transcription factor activity [IDA]
- transcription factor binding [IPI]
- transcription regulatory region DNA binding [IDA]
Gene Ontology Cellular Component
Homo sapiens
PREY
IL6ST
CD130, CDW130, GP130, IL-6RB
interleukin 6 signal transducer
GO Process (18)
GO Function (11)
GO Component (8)
Gene Ontology Biological Process
- ciliary neurotrophic factor-mediated signaling pathway [IDA]
- cytokine-mediated signaling pathway [IDA]
- interleukin-27-mediated signaling pathway [IMP]
- interleukin-6-mediated signaling pathway [IMP]
- leukemia inhibitory factor signaling pathway [IDA]
- negative regulation of apoptotic process [TAS]
- negative regulation of interleukin-6-mediated signaling pathway [IDA]
- oncostatin-M-mediated signaling pathway [IMP]
- positive regulation of T cell proliferation [IMP]
- positive regulation of acute inflammatory response [IC]
- positive regulation of adaptive immune response [IC]
- positive regulation of cardiac muscle hypertrophy [TAS]
- positive regulation of cell proliferation [IDA, IGI]
- positive regulation of osteoblast differentiation [IMP]
- positive regulation of tyrosine phosphorylation of Stat1 protein [IMP]
- positive regulation of tyrosine phosphorylation of Stat3 protein [IMP]
- positive regulation vascular endothelial growth factor production [TAS]
- response to cytokine [IDA]
Gene Ontology Molecular Function- ciliary neurotrophic factor receptor activity [IDA]
- ciliary neurotrophic factor receptor binding [IPI]
- growth factor binding [IPI]
- interleukin-27 receptor activity [IC]
- interleukin-6 binding [IPI]
- interleukin-6 receptor activity [IDA]
- interleukin-6 receptor binding [IPI]
- leukemia inhibitory factor receptor activity [IDA]
- oncostatin-M receptor activity [IDA]
- protein binding [IPI]
- protein homodimerization activity [TAS]
- ciliary neurotrophic factor receptor activity [IDA]
- ciliary neurotrophic factor receptor binding [IPI]
- growth factor binding [IPI]
- interleukin-27 receptor activity [IC]
- interleukin-6 binding [IPI]
- interleukin-6 receptor activity [IDA]
- interleukin-6 receptor binding [IPI]
- leukemia inhibitory factor receptor activity [IDA]
- oncostatin-M receptor activity [IDA]
- protein binding [IPI]
- protein homodimerization activity [TAS]
Gene Ontology Cellular Component
Homo sapiens
Affinity Capture-Western
An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner identified by Western blot with a specific polyclonal antibody or second epitope tag. This category is also used if an interacting protein is visualized directly by dye stain or radioactivity. Note that this differs from any co-purification experiment involving affinity capture in that the co-purification experiment involves at least one extra purification step to get rid of potential contaminating proteins.
Publication
Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
BACKGROUND: Neuroendocrine (NE) differentiation in prostate cancer has been suggested to be one of the early events in the development of androgen independence. In the human prostate cancer LNCaP cell line, treatment with interleukin-6 (IL-6) induces NE-like differentiation, which is similar to the phenomena observed in advanced stages of prostate cancer progression. In this study, we investigate how androgen plays ... [more]
Prostate Jun. 15, 2004; 60(1);61-7 [Pubmed: 15129430]
Throughput
- Low Throughput
Additional Notes
- Androgen treatment enhances the interaction between AR and gp130, interrupts the IL-6-induced gp130-mediated PI3K activation
Curated By
- BioGRID